| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Francesca Aloisi | Q56810648 |
| Elena Ambrosini | Q58629418 | ||
| Barbara Serafini | Q64682632 | ||
| Sandra Columba-Cabezas | Q114430389 | ||
| Barbara Rosicarelli | Q45353555 | ||
| P2093 | author name string | Marco Salvetti | |
| Richard Reynolds | |||
| Diego Franciotta | |||
| Roberta Magliozzi | |||
| Eliana Coccia | |||
| P2860 | cites work | Environmental risk factors for multiple sclerosis. Part I: The role of infection | Q22252937 |
| Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis | Q24300326 | ||
| B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5 | Q24309316 | ||
| BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma | Q24646563 | ||
| A chemokine-driven positive feedback loop organizes lymphoid follicles | Q28142202 | ||
| Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes | Q28250284 | ||
| Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo | Q28263920 | ||
| The immunopathology of multiple sclerosis: an overview | Q28295115 | ||
| A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen | Q28300225 | ||
| Development and maturation of secondary lymphoid tissues. | Q33652498 | ||
| Chemokines and cell migration in secondary lymphoid organs | Q33807114 | ||
| Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice | Q34110300 | ||
| Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. | Q34191599 | ||
| Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephal | Q48494770 | ||
| Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells | Q48660181 | ||
| Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. | Q52022097 | ||
| Turning off follicular dendritic cells | Q59068710 | ||
| CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions | Q60197446 | ||
| Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin β receptor-Ig fusion protein | Q60455093 | ||
| Unveiling the enigma of the CNS as a B-cell fostering environment | Q61657776 | ||
| Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes | Q77522322 | ||
| Recent advances in chemokines and chemokine receptors | Q78165392 | ||
| Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation | Q78952383 | ||
| Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a | Q80319155 | ||
| A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21 | Q80833012 | ||
| Expression of chemokine receptors CCR7 and CCR8 in the CNS during ChREAE | Q81239073 | ||
| CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis | Q83918246 | ||
| Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen | Q34488105 | ||
| Epstein-Barr virus: exploiting the immune system | Q34572150 | ||
| CXCR5(+) T cells: follicular homing takes center stage in T-helper-cell responses | Q34726022 | ||
| Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system | Q35091583 | ||
| Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. | Q35168188 | ||
| Chemokines in the systemic organization of immunity | Q35216944 | ||
| The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity | Q35216957 | ||
| Role of chemokines in the development of secondary and tertiary lymphoid tissues | Q35682757 | ||
| Epstein-barr virus: environmental trigger of multiple sclerosis? | Q35914342 | ||
| A stromal address code defined by fibroblasts | Q36061032 | ||
| The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms | Q36205278 | ||
| Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain | Q36229219 | ||
| Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system | Q36353776 | ||
| Chronic inflammation caused by lymphotoxin is lymphoid neogenesis | Q36366337 | ||
| Ectopic LTαβ Directs Lymphoid Organ Neogenesis with Concomitant Expression of Peripheral Node Addressin and a HEV-restricted Sulfotransferase | Q36370988 | ||
| Lymphoid neogenesis in chronic inflammatory diseases. | Q36405080 | ||
| Lymphoid organ development: from ontogeny to neogenesis | Q36426808 | ||
| BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma | Q36762885 | ||
| Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. | Q37285430 | ||
| The significance of perivascular infiltrations in multiple sclerosis | Q39372080 | ||
| Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis | Q40141450 | ||
| The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis | Q40414775 | ||
| Novel lymphocyte-specific CC chemokines and their receptors. | Q41640121 | ||
| BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. | Q41740089 | ||
| Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions | Q42665157 | ||
| Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. | Q44999948 | ||
| CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. | Q46275246 | ||
| Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. | Q46655434 | ||
| Cytokine CXCL13--a possible early CSF marker for neuroborreliosis | Q46820791 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13. | Q47578671 | ||
| Expression of CCR7 in multiple sclerosis: implications for CNS immunity | Q47661247 | ||
| Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma | Q48099867 | ||
| Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. | Q48200750 | ||
| Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. | Q48325664 | ||
| Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. | Q48390605 | ||
| Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. | Q48409288 | ||
| Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma | Q48462130 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | neuronitis | Q17157137 |
| P304 | page(s) | 106-112 | |
| P577 | publication date | 2008-06-09 | |
| P1433 | published in | Journal of Neuroimmunology | Q15716691 |
| P1476 | title | Lymphoid chemokines in chronic neuroinflammation | |
| P478 | volume | 198 |
| Q55052878 | Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines. |
| Q93047673 | Autoimmune-Mediated Retinopathy in CXCR5-Deficient Mice as the Result of Age-Related Macular Degeneration Associated Proteins Accumulation |
| Q35937581 | B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination. |
| Q34808657 | B cells and multiple sclerosis |
| Q35001976 | CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles |
| Q36161486 | CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation |
| Q51445817 | Chemokine upregulation in response to anal sphincter and pudendal nerve injury: potential signals for stem cell homing. |
| Q41136886 | Chronic progressive multiple sclerosis - pathogenesis of neurodegeneration and therapeutic strategies |
| Q64957483 | Clinical utility of a molecular signature in inflammatory demyelinating disease. |
| Q35929137 | Complexity of the microglial activation pathways that drive innate host responses during lethal alphavirus encephalitis in mice |
| Q34628101 | Detection of cerebral spinal fluid-associated chemokines in birth traumatized premature babies by chip-based immunoaffinity CE. |
| Q37867728 | Development of anti-CD20 therapy for multiple sclerosis. |
| Q26770818 | Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis |
| Q34730335 | Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's Lymphoma |
| Q34076957 | Expression and regulation in the brain of the chemokine CCL27 gene locus |
| Q28535303 | Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosis |
| Q38824089 | Gel-Trapped Lymphorganogenic Chemokines Trigger Artificial Tertiary Lymphoid Organs and Mount Adaptive Immune Responses In Vivo |
| Q28385127 | Immune heterogeneity in neuroinflammation: dendritic cells in the brain |
| Q34544889 | Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis |
| Q26742160 | Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the Lung |
| Q37370568 | Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature |
| Q59350636 | Interferon regulatory factors 3 and 7 have distinct roles in the pathogenesis of alphavirus encephalomyelitis |
| Q38082670 | Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation |
| Q90127592 | Nonproliferative and Proliferative Lesions of the Rat and Mouse Hematolymphoid System |
| Q33772300 | Regulated Production of CXCL13 within the Central Nervous System |
| Q26798209 | Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies |
| Q98895130 | Serum levels of chemokines in adolescents with major depression treated with fluoxetine |
| Q36551188 | Targeting CXCL13 During Neuroinflammation |
| Q35104199 | The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system |
| Q47579410 | The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis |
| Q34083294 | Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. |
Search more.